K22.711 Barrett's esophagus with high grade dysplasia

Name of the Condition

• Barrett's esophagus with high grade dysplasia

Summary

Barrett's esophagus with high grade dysplasia is a precancerous condition where the normal lining of the esophagus is replaced by intestinal-type tissue (intestinal metaplasia) and shows significant abnormal cellular changes (high grade dysplasia). This condition is strongly associated with chronic gastroesophageal reflux disease (GERD) and carries a high risk of progressing to esophageal adenocarcinoma. Diagnosis requires endoscopic evaluation with targeted biopsies to confirm the presence and grade of dysplasia.

Causes

The primary cause is chronic exposure of the esophageal lining to stomach acid and bile, most commonly due to GERD. Long-term acid reflux damages the esophageal epithelium, leading to intestinal metaplasia. High grade dysplasia arises when these abnormal cells undergo severe genetic and structural changes, often driven by persistent inflammation and acid exposure over time.

Risk Factors

• Chronic gastroesophageal reflux disease (GERD)
• Obesity, particularly abdominal obesity
• Male gender
• Age (more common in adults over 50)
• Tobacco use
• Family history of Barrett's esophagus or esophageal cancer

Symptoms

• Chronic heartburn or acid reflux
• Difficulty swallowing (dysphagia)
• Chest pain unrelated to heartburn
• Regurgitation of food or liquid
• Unexplained weight loss (in advanced cases)

Diagnosis

Diagnosis requires an upper endoscopy with targeted biopsies to assess the presence and grade of dysplasia. During the procedure, the esophageal lining is visually inspected, and multiple tissue samples are taken for histopathological analysis. Advanced imaging techniques, such as chromoendoscopy or narrow-band imaging, may be used to enhance detection of abnormal areas.

Treatment Options

Treatment focuses on eliminating dysplasia and preventing progression to cancer. Options include endoscopic therapies (e.g., radiofrequency ablation, endoscopic mucosal resection) to remove or destroy abnormal tissue, or surgical intervention in severe cases. Acid-suppressing medications (proton pump inhibitors) are typically prescribed to manage underlying GERD.

Prognosis and Follow-Up

With appropriate treatment, the risk of progression to esophageal cancer is significantly reduced. Regular endoscopic surveillance is recommended to monitor for recurrence or progression. Follow-up intervals depend on the treatment response and individual risk factors, and may involve periodic biopsies to ensure dysplasia does not return.

Complications

• Progression to esophageal adenocarcinoma
• Stricture formation (narrowing of the esophagus)
• Bleeding from esophageal lesions
• Persistent reflux symptoms despite treatment

Lifestyle & Prevention

• Maintain a healthy weight to reduce abdominal pressure
• Avoid trigger foods that worsen reflux (e.g., spicy, fatty foods)
• Quit smoking and limit alcohol consumption
• Elevate the head of the bed to reduce nighttime reflux
• Eat smaller, more frequent meals

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Sudden or worsening difficulty swallowing
• Unexplained weight loss
• Chest pain or difficulty breathing
• Vomiting blood or black, tarry stools
• Persistent reflux symptoms despite medication

Tips for Medical Coders

Document the presence of high grade dysplasia confirmed by biopsy. Include details of endoscopic findings, biopsy results, and any associated treatments (e.g., ablation, resection). Ensure documentation supports the severity of dysplasia and any surveillance or follow-up plans. Code K22.711 is specific to high grade dysplasia; verify that lower grade dysplasia or no dysplasia is not present, as this would require a different code.